Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
The Edison Histotripsy System is a medical device designed to treat certain liver tumors without surgery. It uses a focused ultrasound technique called histotripsy, which mechanically breaks down tumor tissue by creating tiny bubbles inside the tumor. Unlike other treatments that use heat, freezing, or radiation, histotripsy works by physically disrupting the tumor cells. The procedure is done from outside the body, guided by ultrasound imaging, so it does not require incisions or needles.
For patients with liver tumors that cannot be removed by surgery, histotripsy offers a non-invasive option to locally destroy tumor tissue. This can be important for controlling tumor growth and potentially improving symptoms. It is especially relevant for primary liver cancers like hepatocellular carcinoma and for some cancers that have spread to the liver from other sites, such as colorectal or breast cancer. Because it targets only the visible tumor, histotripsy is usually considered alongside other treatments like surgery, radiation, or systemic therapies, depending on the patient’s overall condition and cancer stage.
If histotripsy is mentioned in your care, you might hear it described as a focused ultrasound treatment that breaks down tumors without cutting or radiation. Your doctor may explain that it is a newer technology approved by the FDA for certain liver tumors but that it is not a cure for cancer. You may also hear that it is still being studied for other tumors like kidney or pancreas cancers. Because it is a local treatment, it only treats the targeted tumor and does not affect cancer cells elsewhere in the body.
It is important to understand that histotripsy is not a systemic cancer treatment. It does not treat cancer cells that have spread beyond the targeted tumor or microscopic disease that cannot be seen on imaging. The FDA approval for the Edison System does not guarantee specific cancer outcomes such as improved survival or long-term tumor control. Histotripsy is one tool among many and is usually part of a broader treatment plan.
Doctors may consider histotripsy for patients with liver tumors that are difficult to remove surgically or when other local treatments are not suitable. It is guided by imaging to precisely target the tumor and minimize damage to surrounding healthy tissue. The decision to use histotripsy depends on tumor size, location, liver function, prior treatments, and overall health. It may be offered as part of clinical trials or specialized cancer care centers.
If histotripsy is suggested, you might ask how it compares to other treatments like surgery or radiation, what the expected benefits and risks are, and how it fits into your overall cancer care plan. It is also reasonable to ask about the experience of the treatment team, what to expect during and after the procedure, and whether there are clinical trials available for your cancer type.
The Edison Histotripsy System is a prescription device used only by trained physicians. While it is FDA-approved for non-invasive destruction of liver tumors, it has not been evaluated for specific cancer outcomes such as survival. This information is educational and does not replace personalized medical advice. Treatment decisions should always be made in consultation with your cancer care team, who can consider your unique situation.
If you hear about histotripsy as a treatment option, talk openly with your doctor about whether it is appropriate for your cancer type and stage. Ask about the availability of this technology at your treatment center and whether clinical trials are an option. Understanding how histotripsy fits into your overall care can help you make informed decisions about your treatment journey.